肿瘤抗原致敏树突状细胞瘤苗治疗颅内胶质瘤的实验研究

被引:15
作者
刘福生
王忠诚
历俊华
林松
任铭
肖庆
张亚卓
机构
[1] 北京市神经外科研究所
关键词
抗原提呈细胞; 树突状细胞; 免疫治疗; 脑肿瘤; 大鼠;
D O I
暂无
中图分类号
R739.4 [神经系肿瘤];
学科分类号
摘要
目的 研究肿瘤抗原致敏树突状细胞瘤苗治疗胶质瘤的疗效。方法 从大鼠的骨髓中加入GM CSF和IL 4培养树突状细胞 ,采用相差显微镜、扫描电镜观察了树突状细胞的形态学特点 ;免疫组织化学双标技术、流式细胞免疫学技术观察了其特异性抗体OX6和OX62 的表达 ;微酸洗脱方法抽提C6肿瘤抗原体外致敏树突状细胞 ,建立C6胶质瘤脑内动物模型 ,体内应用抗原致敏的树突状细胞 ,观察脑内肿瘤的疗效 ,并取致敏的动物的脾脏T细胞体外加入C6肿瘤抗原 ,加入IL 2培养进行CTL活性检测。结果 培养第 8天可见有典型的树突状细胞 ;免疫组织化学双标可见有OX6和OX62 阳性细胞 ,流式细胞免疫学分析发现OX62 阳性率为 93 0 3% ,OX6的阳性率为 92 0 1% ;体外细胞毒试验发现对相应的C6肿瘤细胞有明显的杀伤作用 ;动物实验发现实验组可见肿瘤组织内有大量的坏死 ,而对照组仅有少量的坏死 ,两者相比P <0 0 1。结论 体内注射采用微酸洗脱的抗原肽致敏树突状细胞瘤苗能够引起荷瘤动物脑肿瘤大面积的坏死 ,该方法为将来临床免疫治疗胶质瘤充分调动机体的免疫系统奠定基础。
引用
收藏
页码:24 / 28
页数:5
相关论文
共 9 条
  • [1] Bone marrow-derived dendritic cells pulsed with a tumor-specific peptide elicit effective anti-tumor immunity against intracranial neoplasms. Okada H,Tahara H,Shurin MR,et al. International Journal of Cancer . 1998
  • [2] In vitro characterization of rat bone marrow-derived dendritic cells and their precursors. Chen-Woan M,Delaney CP,Fournier V,et al. Journal of Leukocyte Biology . 1996
  • [3] Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells. Lichtor T,Glick RP,Kim TS,et al. Journal of Neurosurgery . 1995
  • [4] Interactions between lymphocytes, macrophages, and central nervous system cells. Couraud PO. Journal of Leukocyte Biology . 1994
  • [5] Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells,B7 costimulation and T helper cell 1-associtated cytokines. Zitvogel L,Mayordomo JI,Tjandrawan T,et al. The Journal of Experimental Medicine . 1996
  • [6] Immunobiology of malignant astrocytomas. Kurpad SN,Wikstrand CJ,Bigner DD. Seminars in Oncology . 1994
  • [7] Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. Liau LM,Black KL,Prins RM,et al. Journal of Neurosurgery . 1999
  • [8] A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM-CSF, and their quantification using the mAb OX6 2. Chen-Woan M,Delaney CP,Fournier V,et al. Journal of Immunological Methods . 1995
  • [9] Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. Ashley DM,Faiola B,Nair S,et al. The Journal of Experimental Medicine . 1997